Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)
Christian Geßner, Oliver Kornmann, Jorge Máspero, Richard N. van Zyl-Smit, Matthias Krüll, Anna Salina, Pritam Gupta, Sebastien Bostel, Sebastian Fucile, Lorena Garcia Conde, Pascal Pfister
Topics & Concepts
IndacaterolMometasone furoateMedicineSalmeterolAsthmaFluticasone propionateCorticosteroidFluticasoneBeclometasone dipropionateAnesthesiaInternal medicineBronchodilatorRespiratory diseaseLungAsthma and respiratory diseasesPharmacological Effects and AssaysInhalation and Respiratory Drug Delivery